CAS No. |
512-06-1 |
|---|---|
英文名称 |
5',6a,8a,9-tetramethyl-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-icosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4-ol |
别名 |
(20α,22R,25S)-Spirosta-5-ene-3β-ol;(25S)-Spirost-5-en-3β-ol;Yamogenin;Nsc 226132;Spirost-5-en-3-ol, (3beta,25S)-;Neodiosgenin;Spirost-5-en-3-ol, (3β,25S)-;Yamogenin-RM |
标准英文名 |
5',6a,8a,9-tetramethyl-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-icosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4-ol |
分子式 |
C27H42O3 |
分子量 |
414.63 |
精确分子量 |
414.31 |
SMILES |
CC1CCC2(OC1)OC1CC3C4CC=C5CC(O)CCC5(C)C4CCC3(C)C1C2C |
标准SMILES |
CC1COC2(CC1)OC1CC3C4CC=C5CC(O)CCC5(C)C4CCC3(C)C1C2C |
用途 |
Yamogenin (Neodiosgenin) is a diastereomer of diosgenin and serves as an important steroidal sapogenin and a key starting material for the semi-synthesis of steroidal compounds. It acts as an antagonist of liver X receptor (LXR) activation in luciferase ligand assays and inhibits triglyceride (TG) accumulation in HepG2 hepatocytes by suppressing the expression of genes involved in fatty acid synthesis. |
InChIKey |
WQLVFSAGQJTQCK-UHFFFAOYSA-N |
|
|
评论 |
|---|